736
Views
27
CrossRef citations to date
0
Altmetric
Review

Neuropsychological, electrophysiological, and neuroimaging biomarkers for REM behavior disorder

, , , &
Pages 1069-1087 | Received 28 Mar 2019, Accepted 03 Jul 2019, Published online: 11 Jul 2019

References

  • Schenck CH, Bundlie SR, Ettinger MG, et al. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep. 1986;9(2):293–308.
  • Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology. 1996;46(2):388–393.
  • Högl B, Stefani A, Videnovic A. Idiopathic REM sleep behaviour disorder and neurodegeneration - an update. Nat Rev Neurol. 2018;14(1):40–55.
  • Galbiati A, Verga L, Giora E, et al. The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies. Sleep Med Rev. 2019;43:37–46.
  • American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed. Darien: American Academy of Sleep Medicine; 2014.
  • Haba-Rubio J, Frauscher B, Marques-Vidal P, et al. Prevalence and determinants of REM sleep behavior disorder in the general population. Sleep. 2017. DOI:10.1093/sleep/zsx197.
  • McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88–100.
  • Kimura K, Tachibana N, Kohyama J, et al. A discrete pontine ischemic lesion could cause REM sleep behavior disorder. Neurology. 2000;55(6):894–895.
  • Ju YE, Larson-Prior L, Duntley S. Changing demographics in REM sleep behavior disorder: possible effect of autoimmunity and antidepressants. Sleep Med. 2011;12(3):278–283.
  • Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5(6):463–466.
  • Manni R, Sinforiani E, Pacchetti C, et al. Cognitive dysfunction and REM sleep behavior disorder: key findings in the literature and preliminary longitudinal findings. Int J Psychophysiol. 2013;89(2):213–217.
  • Massicotte-Marquez J, Decary A, Gagnon JF, et al. Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology. 2008;70(15):1250–1257.
  • Ferini-Strambi L, Di Gioia MR, Castronovo V, et al. Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): does the idiopathic form of RBD really exist? Neurology. 2004;62(1):41–45.
  • Gagnon JF, Vendette M, Postuma RB, et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson’s disease. Ann Neurol. 2009;66(1):39–47.
  • Plomhause L, Dujardin K, Boucart M, et al. Impaired visual perception in rapid eye movement sleep behavior disorder. Neuropsychology. 2014;28(3):388.
  • Li X, Zhou Z, Jia S, et al. Cognitive study on Chinese patients with idiopathic REM sleep behavior disorder. J Neurol Sci. 2016;366:82–86.
  • Terzaghi M, Sinforiani E, Zucchella C, et al. Cognitive performance in REM sleep behaviour disorder: a possible early marker of neurodegenerative disease? Sleep Med. 2008;9(4):343–351.
  • Marques A, Dujardin K, Boucart M, et al. REM sleep behaviour disorder and visuoperceptive dysfunction: a disorder of the ventral visual stream? J Neurol. 2010;257(3):383–391.
  • Rolinski M, Zokaei N, Baig F, et al. Visual short-term memory deficits in REM sleep behaviour disorder mirror those in Parkinson’s disease. Brain. 2015;139(1):47–53.
  • Li X, Wang K, Jia S, et al. The prospective memory of patients with idiopathic REM sleep behavior disorder. Sleep Med. 2018;47:19–24.
  • Fantini ML, Farini E, Ortelli P, et al. Longitudinal study of cognitive function in idiopathic REM sleep behavior disorder. Sleep. 2011;34(5):619–625.
  • Terzaghi M, Zucchella C, Rustioni V, et al. Cognitive performances and mild cognitive impairment in idiopathic rapid eye movement sleep behavior disorder: results of a longitudinal follow-up study. Sleep. 2013;36(10):1527–1532.
  • Youn S, Kim T, Yoon IY, et al. Progression of cognitive impairments in idiopathic REM sleep behaviour disorder. J Neurol Neurosurg Psychiatry. 2016;87(8):890–896.
  • Chwiszczuk L, Breitve MH, Brønnick K, et al. REM sleep behavior disorder is not associated with a more rapid cognitive decline in mild dementia. Front Neurol. 2017;8:375.
  • Boeve BF, Molano JR, Ferman TJ, et al. Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort. Sleep Med. 2011;12(5):445–453.
  • Marchand DG, Montplaisir J, Postuma RB, et al. Detecting the cognitive prodrome of dementia with Lewy bodies: a prospective study of REM sleep behavior disorder. Sleep. 2017;40(1). DOI:10.1093/sleep/zsw014.
  • Marchand DG, Postuma RB, Escudier F, et al. How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder. Ann Neurol. 2018;83(5):1016–1026.
  • Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126–135.
  • Zhang JR, Chen J, Yang ZJ, et al. Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease. Chin Med J (Engl). 2016;129(4):379.
  • Molano J, Boeve B, Ferman T, et al. Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study. Brain. 2009;133(2):540–556.
  • Jung Y, Boot BP, Mielke MM, et al. Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population-based sample. Alzheimers Dement (Amst). 2017;8:127–130.
  • Postuma RB, Iranzo A, Hu M, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain. 2019;142(3):744–759.
  • Fantini LM, Gagnon JF, Petit D, et al. Slowing of electroencephalogram in rapid eye movement sleep behavior disorder. Ann Neurol. 2003;53(6):774–780.
  • Penttila M, Partanen JV, Soininen H, et al. Quantitative analysis of occipital EEG in different stages of Alzheimer’s disease. Electroencephalogr Clin Neurophysiol. 1985;60:1–6.
  • Prichep LS, John ER, Ferris SH, et al. Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiol Aging. 1994;15:85–90.
  • Klassen BT, Hentz JG, Shill HA, et al. Quantitative EEG as a predictive biomarker for Parkinson disease dementia. Neurology. 2011;77:118–124.
  • Williamson PC, Merskey H, Morrison S, et al. Quantitative electroencephalographic correlates of cognitive decline in normal elderly subjects. Arch Neurol. 1990;47:1185–1188.
  • Prinz PN, Vitaliano PP, Vitiello MV, et al. Sleep, EEG and mental function changes in senile dementia of the Alzheimer’s type. Neurobiol Aging. 1982;3:361–370.
  • Barber PA, Varma AR, Lloyd JJ, et al. The electroencephalogram in dementia with Lewy bodies. Acta Neurol Scand. 2000;101:53–56.
  • Serizawa K, Kamei S, Morita A, et al. Comparison of quantitative EEGs between Parkinson disease and age-adjusted normal controls. J Clin Neurophysiol. 2008;25:361–366.
  • Rodrigues Brazète J, Montplaisir J, Petit D, et al. Electroencephalogram slowing in rapid eye movement sleep behavior disorder is associated with mild cognitive impairment. Sleep Med. 2013;14(11):1059–1063.
  • Bang YR, Jeon HJ, Youn S, et al. Alterations of awake EEG in idiopathic REM sleep behavior disorder without cognitive impairment. Neurosci Lett. 2017;637:64–69.
  • Sasai T, Matsuura M, Inoue Y. Electroencephalographic findings related with mild cognitive impairment in idiopathic rapid eye movement sleep behavior disorder. Sleep. 2013;36:1893–1899.
  • Kai T, Asai Y, Sakuma K, et al. Quantitative electroencephalogram analysis in dementia with Lewy bodies and Alzheimer’s disease. J Neurol Sci. 2005;237:89–95.
  • Raggi A, Manconi M, Consonni M, et al. Event-related potentials in idiopathic rapid eye movements sleep behaviour disorder. Clin Neurophysiol. 2007;118(3):669–675.
  • Byun JI, Lee BU, Sunwoo JS, et al. Reduced P300 amplitude during a visuospatial attention task in idiopathic rapid eye movement sleep behavior disorder. Sleep Med. 2017;38:78–84.
  • Kok A. On the utility of P3 amplitude as a measure of processing capacity. Psychophysiology. 2001;38(3):557–577.
  • Li M, Kuroiwa Y, Wang L, et al. Early sensory information processes are enhanced on visual oddball and S1-S2 tasks in Parkinson’s disease: a visual event-related potentials study. Parkinsonism Relat Disord. 2003;9(6):329–340.
  • Solis-Vivanco R, Ricardo-Garcell J, Rodriguez-Camacho M, et al. Involuntary attention impairment in early Parkinson’s disease: an event-related potential study. Neurosci Lett. 2011;495(2):144–149.
  • Vermeiren Y, De Deyn PP. Targeting the norepinephrinergic system in Parkinson’s disease and related disorders: the locus coeruleus story. Neurochem Int. 2017;102:22–32.
  • Seidel K, Mahlke J, Siswanto S, et al. The brainstem pathologies of Parkinson’s disease and dementia with Lewy bodies. Brain Pathol. 2015;25(2):121–135.
  • Iranzo A, Valldeoriola F, Lomena F, et al. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol. 2011;10(9):797–805.
  • Arnaldi D, Fama F, De Carli F, et al. The role of the serotonergic system in REM sleep behavior disorder. Sleep. 2015;38(9):1505–1509.
  • Rodrigues Brazète J, Gagnon JF, Postuma RB, et al. Electroencephalogram slowing predicts neurodegeneration in rapid eye movement sleep behavior disorder. Neurobiol Aging. 2016;37:74–81.
  • Bonanni L, Thomas A, Tiraboschi P, et al. EEG comparisons in early Alzheimer’s disease, dementia with Lewy bodies and Parkinson’s disease with dementia patients with a 2-year follow-up. Brain. 2008;131(3):690–705.
  • Agarwal S, Koch G, Hillis AE, et al. Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke. J Neurol Neurosurg Psychiatry. 2019;90(1):47–57.
  • Nardone R, Brigo F, Versace V, et al. Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson’s disease: a reappraisal. J Neural Transm. 2017;124(11):1417–1429.
  • Schmeichel AM, Buchhalter LC, Low PA, et al. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy. Neurology. 2008;70(5):368–373.
  • Di Lazzaro V, Pilato F, Dileone M, et al. Functional evaluation of cerebral cortex in dementia with Lewy bodies. Neuroimage. 2007;37(2):422–449.
  • Nardone R, Bergmann J, Christova M, et al. Short latency afferent inhibition differs among the subtypes of mild cognitive impairment. J Neural Transm. 2012a;119:463–471.
  • Nardone R, Bergmann J, Kunz A, et al. Cortical afferent inhibition is reduced in patients with idiopathic REM sleep behavior disorder and cognitive impairment: a TMS study. Sleep Med. 2012b;13(7):919–925.
  • Fries P. A mechanism for cognitive dynamics: neuronal communication through neuronal coherence. Trends Cogn Sci. 2005;9(10):474–480.
  • Pievani M, de Haan W, Wu T, et al. Functional network disruption in the degenerative dementias. Lancet Neurol. 2011;10(9):829–843.
  • Ellmore TM, Castriotta RJ, Hendley KL, et al. Altered nigrostriatal and nigrocortical functional connectivity in rapid eye movement sleep behavior disorder. Sleep. 2013;36(12):1885–1892.
  • Rolinski M, Griffanti L, Piccini P, et al. Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson’s disease. Brain. 2016;139(8):2224–2234.
  • Sunwoo JS, Lee S, Kim JH, et al. Altered functional connectivity in idiopathic rapid eye movement sleep behavior disorder: a resting-state EEG study. Sleep. 2017; 40(6).
  • Bertrand JA, McIntosh AR, Postuma RB, et al. Brain connectivity alterations are associated with the development of dementia in Parkinson’s disease. Brain Connect. 2016;6(3):216–224.
  • Olde Dubbelink KT, Stoffers D, Deijen JB, et al. Resting-state functional connectivity as a marker of disease progression in Parkinson’s disease: a longitudinal MEG study. Neuroimage Clin. 2013;2:612–619.
  • Bosboom JL, Stoffers D, Wolters EC, et al. MEG resting state functional connectivity in Parkinson’s disease related dementia. J Neural Transm. 2009;116(2):193–202.
  • Tóth B, File B, Boha R, et al. EEG network connectivity changes in mild cognitive impairment: preliminary results. Int J Psychophysiol. 2014;92(1):1–7.
  • Ruffini G, Ibanez D, Kroupi E, et al. Algorithmic complexity of EEG for prognosis of neurodegeneration in idiopathic rapid eye movement behavior disorder (RBD). Ann Biomed Eng. 2019;47(1):282–296.
  • Lu J, Sherman D, Devor M, et al. A putative flip-flop switch for control of REM sleep. Nature. 2006;441(7093):589–594.
  • Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 2001;24:726–731.
  • Saper CB, Fuller PM, Pedersen NP, et al. Sleep State Switching. Neuron. 2010;68:1023–1042.
  • Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging. 2003;24:197–211.
  • Christensen JA, Koch H, Frandsen R, et al. Classification of iRBD and Parkinson’s disease patients based on eye movements during sleep. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:441–444.
  • Christensen JAE, Zoetmulder M, Koch H, et al. Data-driven modeling of sleep EEG and EOG reveals characteristics indicative of pre-Parkinson’s and Parkinson’s disease. J Neurosci Methods. 2014;235:262–276.
  • Christensen JAE, Jennum P, Koch H, et al. Sleep stability and transitions in patients with idiopathic REM sleep behavior disorder and patients with Parkinson’s disease. Clin Neurophysiol. 2016;127(1):537–543.
  • Ioannides AA, Corsi-Cabrera M, Fenwick PB, et al. MEG tomography of human cortex and brainstem activity in waking and REM sleep saccades. Cereb Cortex. 2004;14(1):56–72.
  • Christensen JAE, Frandsen R, Kempfner J, et al. Separation of Parkinson’s patients in early and mature stages from control subjects using one EOG channel. 34th Annual International Conference of the IEEE EMBS, San Diego, CA, USA. 2012;2941–2944.
  • Petit D, Gagnon JF, Fantini ML, et al. Sleep and quantitative EEG in neurodegenerative disorders. J Psychosom Res. 2004;56(5):487–496.
  • Iranzo A, Isetta V, Molinuevo JL, et al. Electroencephalographic slowing heralds mild cognitive impairment in idiopathic REM sleep behavior disorder. Sleep Med. 2010;11(6):534–539.
  • Hansen IH, Marcussen M, Christensen JA, et al. Detection of a sleep disorder predicting Parkinson’s disease. Conf Proc IEEE Eng Med Biol Soc. 2013;2013:5793–5796.
  • Vendette M, Montplaisir JN, Gosselin N, et al. Brain perfusion anomalies in rapid eye movement sleep behavior disorder with mild cognitive impairment. Mov Disord. 2012;27:1255–1261.
  • Fujishiro H, Iseki E, Murayama N, et al. Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies. Psychogeriatrics. 2010;10:144–152.
  • Latreille V, Carrier J, Montplaisir J, et al. Non-rapid eye movement sleep characteristics in idiopathic REM sleep behavior disorder. J Neurol Sci. 2011;310:159–162.
  • Massicotte-Marquez J, Carrier J, Décary A, et al. Slow-wave sleep and delta power in rapid eye movement sleep behavior disorder. Ann Neurol. 2005;57(2):277–282.
  • Christensen JA, Kempfner J, Zoetmulder M, et al. Decreased sleep spindle density in patients with idiopathic REM sleep behavior disorder and patients with Parkinson’s disease. Clin Neurophysiol. 2014;125(3):512–519.
  • Latreille V, Carrier J, Lafortune M, et al. Sleep spindles in Parkinson’s disease may predict the development of dementia. Neurobiol Aging. 2015;36(2):1083–1090.
  • Hanif U, Trap L, Jennum P, et al. Quantification of muscle activity during sleep for patients with neurodegenerative diseases. Conf Proc IEEE Eng Med Biol Soc. 2015;2015:6002–6005.
  • Boeve BF, Silber MH, Saper CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130:2770–2788.
  • Iranzo A, Ratti PL, Casanova-Molla J, et al. Excessive muscle activity increases over time in idiopathic REM sleep behavior disorder. Sleep. 2009;32(9):1149–1153.
  • Postuma RB, Gagnon JF, Rompré S, et al. Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease. Neurology. 2010;74(3):239–244.
  • Gjerstad MD, Boeve B, Wentzel-Larsen T, et al. Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson’s disease over time. J Neurol Neurosurg Psychiatry. 2008;79:387–391.
  • Stefani A, Gabelia D, Högl B, et al. Long-term follow-up investigation of isolated rapid eye movement sleep without atonia without rapid eye movement sleep behavior disorder: a pilot study. J Clin Sleep Med. 2015;11(11):1273–1279.
  • Liu Y, Zhang J, Lam SP, et al. Electromyography activity level in rapid eye movement sleep predicts neurodegenerative diseases in idiopathic rapid eye movement sleep behavior disorder: a 5-year longitudinal study. Sleep Med. 2019;56:128–134.
  • Treglia G, Stefanelli A, Cason E, et al. Diagnostic performance of iodine 123-metaiodiobenzylguanidine scintigraphy in differential diagnostic between Parkinson’s disease and multiple system atrophy: a systematic review and meta-analysis. Clin Neurol Neurosurg. 2011;113(10):823–829.
  • Fujishiro H, Frigerio R, Burnett M, et al. Cardiac sympathetic degeneration correlates with clinical and pathological stages of Parkinson’s disease. Mov Disord. 2008;23(8):1085–1092.
  • Knudsen K, Fedorova TD, Hansen AK, et al. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. 2018;17:618–628.
  • Miyamoto T, Miyamoto M, Inoue Y, et al. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology. 2006;67:2236–2238.
  • Koyama S, Tachibana N, Masaoka Y, et al. Decreased myocardial 123I‐MIBG uptake and impaired facial expression recognition in a patient with REM sleep behavior disorder. Mov Disord. 2007;22:746–747.
  • Kashihara K, Imamura T, Shinya T. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson’s disease. Parkinsonism Relat Disord. 2010;16:252–255.
  • Paglionico S, Labate A, Salsone M, et al. Involvement of cardiac sympathetic nerve endings in a patient with idiopathic RBD and intact nigrostriatal pathway. Parkinsonism Relat Disord. 2009;15(10):789–791.
  • Labate A, Salsone M, Novellino F, et al. Combined use of cardiac m-i123-iodobenzylguanidine scintigraphy and 123I-fp-cit single photon emission computed tomography in older adults with rapid eye movement sleep behavior disorder. J Am Geriatr Soc. 2011;59(5):928–929.
  • Salsone M, Labate A, Quattrone A. Cardiac denervation precedes nigrostriatal damage in idiopathic rapid eye movement sleep behavior disorder. Mov Disord. 2012;27:1068–1069.
  • Miyamoto T, Miyamoto M, Iwanami M, et al. Follow‐up study of cardiac 123I‐MIBG scintigraphy in idiopathic REM sleep behavior disorder. Eur J Neurol. 2011;18:1275–1278.
  • Zecca L, Casella L, Albertini A, et al. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson’s disease. J Neurochem. 2008;106(4):1866–1875.
  • García-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, et al. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease. Brain. 2013;136(7):2120–2129.
  • Ehrminger M, Latimier A, Pyatigorskaya N, et al. The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder. Brain. 2016;139:1180–1188.109.
  • Rupprecht S, Walther B, Gudziol H, et al. Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder. Sleep Med. 2013;14:1064–1070.
  • Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30:1591–1601.
  • Albin RL, Koeppe RA, Chervin RD, et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology. 2000;55:1410–1412.
  • Arnaldi D, De Carli F, Picco A, et al. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder? Neurobiol Aging. 2015;36:3300–3305.
  • Eisensehr I, Linke R, Noachtar S, et al. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder Comparison with Parkinson’s disease and controls. Brain. 2000;123:1155–1160.
  • Eisensehr I, Linke R, Tatsch K, et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson’s disease, and controls. Sleep. 2003;26:507–512.
  • Frosini D, Cosottini M, Donatelli G, et al. Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder. Parkinsonism Relat Disord. 2017;43:105–109.
  • Stiasny-Kolster K, Doerr Y, Möller JC, et al. Combination of “idiopathic”REM sleep behaviour disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain. 2004;128:126–137.
  • Kim YK, Yoon I, Kim J, et al. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder. Eur J Neurol. 2010;17:487–492.
  • Iranzo A, Santamaría J, Valldeoriola F, et al. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder. Ann Neurol. 2017;82:419–428.
  • Li Y, Kang W, Yang Q, et al. Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases. Neurology. 2017;88:1493–1500.
  • Tao A, Chen G, Deng Y, et al. Accuracy of transcranial sonography of the substantia nigra for detection of Parkinson’s disease: a systematic review and meta-analysis. Ultrasound Med Biol. 2019;45(3):628–641.
  • Shin HY, Joo EY, Kim ST, et al. Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinson’s disease and normal control. Neurol Sci. 2013;34:935–940.
  • Stockner H, Iranzo A, Seppi K, et al. Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder. Mov Disord. 2009;24:1906–1909.
  • Iwanami M, Miyamoto T, Miyamoto M, et al. Relevance of substantia nigra hyperechogenicity and reduced odor identification in idiopathic REM sleep behavior disorder. Sleep Med. 2010;11:361–365.
  • Iranzo A, Lomeña F, Stockner H, et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol. 2010;9:1070–1077.
  • Iranzo A, Stockner H, Serradell M, et al. Five‐year follow‐up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder. Mov Disord. 2014;29:1774–1780.
  • Wang J, Huang Z, Li Y, et al. Neuromelanin-sensitive MRI of the substantia nigra: an imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson’s disease. Parkinsonism Relat Disord. 2019;58:3–8.
  • Novellino F, Cherubini A, Chiriaco C, et al. Brain iron deposition in essential tremor: a quantitative 3-Tesla magnetic resonance imaging study. Mov Disord. 2013;28(2):196–200.
  • Homayoon N, Pirpamer L, Franthal S, et al. Nigral iron deposition in common tremor disorders. Mov Disord. 2019;34(1):129–132.
  • Heller J, Brcina N, Dogan I, et al. Brain imaging findings in idiopathic REM sleep behavior disorder (RBD) -A systematic review on potential biomarkers for neurodegeneration. Sleep Med Rev. 2017;34:23–33.
  • Pyatigorskaya N, Gaurav R, Arnaldi D, et al. Magnetic resonance imaging biomarkers to assess substantia nigra damage in idiopathic rapid eye movement sleep behavior disorder. Sleep. 2017;40:zsx149.
  • Mazza S, Soucy JP, Gravel P, et al. Assessing whole brain perfusion changes in patients with REM sleep behavior disorder. Neurology. 2006;67:1618–1622.
  • Cochrane CJ, Ebmeier KP. Diffusion tensor imaging in parkinsonian syndromes: a systematic review and meta-analysis. Neurology. 2013;80(9):857–864.
  • Vendette M, Gagnon J, Soucy J, et al. Brain perfusion and markers of neurodegeneration in rapid eye movement sleep behavior disorder. Mov Disord. 2011;26:1717–1724.
  • Hanyu H, Inoue Y. Regional cerebral blood flow changes in patients with idiopathic REM sleep behavior disorder. Eur J Neurol. 2011;18:784–788.
  • Shirakawa S, Takeuchi N, Uchimura N, et al. Study of image findings in rapid eye movement sleep behavioural disorder. Psychiatry Clin Neurosci. 2002;56:291–292.
  • Sakurai H, Hanyu H, Inoue Y, et al. Longitudinal study of regional cerebral blood flow in elderly patients with idiopathic rapid eye movement sleep behavior disorder. Geriatr Gerontol Int. 2014;14:115–120.
  • Ge J, Wu P, Peng S, et al. Assessing cerebral glucose metabolism in patients with idiopathic rapid eye movement sleep behavior disorder. J Cereb Blood Flow Metab. 2015;35:2062–2069.
  • Wu P, Yu H, Peng S, et al. Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder. Brain. 2014;137:3122–3128.
  • Meles SK, Renken RJ, Janzen A, et al. The metabolic pattern of idiopathic REM sleep behavior disorder reflects early-stage Parkinson disease. J Nucl Med. 2018;59:1437–1444.
  • Arnaldi D, Meles SK, Giuliani A, et al. Brain glucose metabolism heterogeneity in idiopathic REM sleep behavior disorder and in Parkinson’s disease. J Park Dis. 2019;9:229–239.
  • Magistretti PJ. Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling. Brain Res. 2000;886:108–112.
  • Holtbernd F, Gagnon J-F, Postuma RB, et al. Abnormal metabolic network activity in REM sleep behavior disorder. Neurology. 2014;82:620–627.
  • Meles SK, Vadasz D, Renken RJ, et al. FDG PET, dopamine transporter SPECT, and olfaction: combining biomarkers in REM sleep behavior disorder. Mov Disord. 2017;32:1482–1486.
  • Shehzad Z, Kelly AMC, Reiss PT, et al. The resting brain: unconstrained yet reliable. Cereb Cortex. 2009;19:2209–2229.
  • Biswal BB, Mennes M, Zuo X-N, et al. Toward discovery science of human brain function. Proc Natl Acad Sci. 2010;107:4734–4739.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.